The Evolving Role of ADC-Based BCMA Targeting in RRMM: Evidence-Led Practicalities of Early Intervention
Saturday, May 16th – 12:00–13:15 CEST
Chair
Maria-Victoria Mateos
Speaker
Paul Richardson
Speaker
Karthik Ramasamy
| AGENDA | |
|---|---|
| 5 mins | Chair’s Introduction: Navigating Treatment Decisions at First Relapse Maria-Victoria Mateos |
| 10 mins | BCMA Targeting at First Relapse: Advancing Care After 1L? Maria-Victoria Mateos |
| 25 mins | Clinical Trial Evidence in Focus: Belantamab Mafodotin in Early RRMM Paul Richardson |
| 20 mins | From Evidence to Everyday Practice: Optimising Belantamab Mafodotin Use Karthik Ramasamy |
| 15 mins | What Matters Most in RRMM?: Aligning Clinical Outcomes with Patient Needs Panel Discussion led by Maria-Victoria Mateos |
